CIK 0001533998 · Non-accelerated filer<br>Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452973162
- Phone
- 972-4-770-6377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- SD Other Specialized Disclosure
- 4/A Grant or award Chief Executive Officer acquired 415,426 shares (grant or award)
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 4 Grant or award Chief Financial Officer acquired 357 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 673 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 346 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K/A Event Acquisition or sale completed
- 4/A Grant or award Director acquired 20,000 shares (grant or award)
- 4/A Grant or award President, GM of North America acquired 91,652 shares (grant or award)
- 4/A Open-market buy Director bought 43,850 shares
- 4/A Grant or award Director acquired 29,616 shares (grant or award)
- 4/A Grant or award Director acquired 17,620 shares (grant or award)
- 10-K Report Annual Report
Page 15 of 46 · 905 filings